Jacobetz, Michael A <br/><br/>
Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer.  [electronic resource] 

 -  Gut  Jan 2013 
 - 112-20 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1468-3288 
<br/><br/><label>Standard No.: </label>10.1136/gutjnl-2012-302529  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Biomarkers, Tumor--physiology<br/>Carcinoma, Pancreatic Ductal--blood supply<br/>Cell Adhesion Molecules--administration & dosage<br/>Deoxycytidine--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Drug Delivery Systems<br/>Drug Resistance, Neoplasm--drug effects<br/>Hyaluronic Acid--physiology<br/>Hyaluronoglucosaminidase--administration & dosage<br/>Immunohistochemistry<br/>Kaplan-Meier Estimate<br/>Mice<br/>Mice, Transgenic<br/>Pancreatic Neoplasms--blood supply<br/>Recombinant Proteins--administration & dosage<br/>Tissue Array Analysis<br/>Treatment Outcome<br/>Gemcitabine